AMGXFAMGXFOTC
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank79
5Y CAGR-7.8%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-7.8%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 41.91% |
| Q3 2025 | 15531.71% |
| Q2 2025 | -99.33% |
| Q1 2025 | 14414.11% |
| Q4 2024 | 0.00% |
| Q2 2024 | 31.15% |
| Q1 2024 | -27.15% |
| Q4 2023 | -20.38% |
| Q3 2023 | 5.70% |
| Q2 2023 | 0.36% |
| Q1 2023 | -36.10% |
| Q4 2022 | 29.36% |
| Q3 2022 | -56.08% |
| Q2 2022 | 91.85% |
| Q1 2022 | -1.13% |
| Q4 2021 | -35.01% |
| Q3 2021 | 38.61% |
| Q2 2021 | 5.36% |
| Q1 2021 | 26.15% |
| Q4 2020 | 146.86% |
| Q3 2020 | 62.84% |
| Q2 2020 | -24.17% |
| Q1 2020 | 0.12% |
| Q4 2019 | 37.25% |
| Q3 2019 | 4.79% |
| Q2 2019 | -37.10% |
| Q1 2019 | -22.06% |
| Q4 2018 | 5.22% |
| Q3 2018 | 110.99% |
| Q2 2018 | -0.44% |
| Q1 2018 | -3.58% |
| Q4 2017 | -47.17% |
| Q3 2017 | 53.05% |
| Q2 2017 | -40.99% |
| Q1 2017 | -12.15% |
| Q4 2016 | 27.27% |
| Q3 2016 | -44.79% |
| Q2 2016 | 43.07% |
| Q1 2016 | 4.48% |
| Q4 2015 | 8.65% |